More than 100 years ago, Einthoven reported the presence of ST-segment changes on electrocardiography in a patient during exercise.1 His discovery led to the development of the modern-day stress test. In patients with known coronary artery disease, the stress test is useful in assessing residual ischemia after an acute myocardial infarction or in cases of incomplete revascularization or when treating symptomatic patients who have had previous revascularization. It is also commonly used to guide exercise therapies before cardiac rehabilitation. Less is known regarding the role of routine surveillance stress testing in asymptomatic patients after percutaneous coronary intervention (PCI). The 2021 . . .
Funding and Disclosures
Disclosure forms provided by the author are available with the full text of this editorial at NEJM.org.
This editorial was published on August 28, 2022, at NEJM.org.
Print Subscriber? Activate your online access.